Clinical Research

Our team of highly trained specialists is dedicated to offering patients the most advanced treatment available for their condition through clinical research.

Neuro-Oncology Clinical Trials

If you are interested in learning more about one of our ongoing clinical trials, please feel free to call our Clinical Research Program at 520-320-2147.

Glioblastoma Clinical Trial – Now Enrolling

Glioblastoma Study: Nativis VOYAGER

This feasibility study will assess the effects of the Nativis Voyager therapy in patients newly diagnosed with GBM (Glioblastoma Multiforme). The study will enroll and treat up to 11 subjects and will be combined with standard of care radiotherapy and temozolomide.

Glioblastoma Clinical Trial – Now Enrolling

Glioblastoma Study: Boston Biomedical Wizard Study

This study will help us learn more about a newly discovered vaccine drug that is being tested in people with recurrent or progressive glioblastoma, who have already received treatment.

Glioblastoma Clinical Trial – Now Enrolling

Recurrent and Newly Diagnosed Glioblastoma: BeiGene BGB-290 Study

This study is to evaluate the safety, efficacy and clinical activity of BGB-290 in combination with radiation therapy (RT) and/or temozolomide (TMZ) in subjects with newly diagnosed or recurrent/refractory glioblastoma.

Learn more at ClinicalTrials

Identifier (NCT): NCT03276286